Alberto Farolfi, MD, is an italian medical oncologist at Romagnolo Scientific Institute for the Study and Treatment of Tumors (IRCCS IRST), Meldola, Italy. His major clinical and research interests include gynecological malignancies and genitourinary tumors, but he also specialized in breast cancer research and treatment. Dr Farolfi completed his clinical training in Medical Oncology at University of Ferrara in 2015 and he is currently performing a PhD program in Oncology, Hematology and Pathology at University of Bologna. His research focuses on clinical and translational research related to outcomes research, identification of predictive biomarkers of treatment response, tumor microenvironment and defects in DNA repair systems. Dr Farolfi has published several original papers in peer-reviewed journals, and he is member of many medical societies